Insufficient Quantities. If Syndax determines that the quantities of the Genentech Compound specified in the Compound Supply Plan are not sufficient to reach Study Completion, Syndax shall so notify Genentech. The Parties shall discuss the additional quantities of the Genentech Compound needed and the schedule on which Genentech shall supply such additional quantities. If Genentech reasonably believes that it will not be able supply such additional quantities of the Genentech Compound, Genentech shall not be deemed in breach of this Agreement, but shall provide prompt written notice to Syndax of the shortage (including the quantity of the Genentech Compound that Genentech reasonably determines it will be able to supply) and the Parties shall ***.
Appears in 3 contracts
Sources: Combination Study Collaboration Agreement (Syndax Pharmaceuticals Inc), Combination Study Collaboration Agreement (Syndax Pharmaceuticals Inc), Combination Study Collaboration Agreement (Syndax Pharmaceuticals Inc)